You have 9 free searches left this month | for more free features.

CLL

Showing 1 - 25 of 1,319

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Ibrutinib 420 mg
  • (no location specified)
Jan 12, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Questionnaires
  • Fit Bit
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Study of the Metabolism in the Lymphatic Niche of CLL

    Recruiting
    • CLL
    • NO intervention
    • Nice, France
      Nice University Hospital
    Nov 2, 2022

    CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

    Terminated
    • CLL
    • SLL
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2023

    Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

    Completed
    • Leukemia, Chronic Lymphatic
    • Stuttgart, Baden-Wuerttemberg, Germany
    • +4 more
    Nov 24, 2022

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

    Recruiting
    • AML, Adult
    • CLL1 CAR-NK cell injection
    • Hangzhou, Zhejiang, China
      Clinical research ethics committee of the first affiliated hospi
    Aug 30, 2023

    Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

    Active, not recruiting
    • Chronic Lymphocytic Leucemia
    • Cologne, Germany
      German CLL Study Group
    Sep 14, 2022

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    CLL/SLL Trial in Beijing (orelabrutinib)

    Recruiting
    • CLL/SLL
    • Beijing, Beijing, China
    • +1 more
    Aug 5, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Chronic Lymphocytic Leukemia Trial in Russian Federation

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Irkutsk, Russian Federation
      • +5 more
      Jan 17, 2023

      Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

      Terminated
      • Chronic Lymphocytic Leukemia(CLL)
      • Small Lymphocytic Lymphoma
      • Hackensack, New Jersey
        Hackensack University Medical Center
      Jun 24, 2022

      Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

      Recruiting
      • Acute Myeloid Leukemia
      • CLL1 and CD38 dual-target CAR-T injection
      • Kunming, Yunnan, China
        920th Hospital of Joint LogisticsSupport Force of People's Liber
      Oct 26, 2023

      Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 20, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Dec 5, 2022

      CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

      Not yet recruiting
      • CLL/SLL
      • Antwerpen, Belgium
      • +23 more
      Mar 28, 2023

      Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

      Active, not recruiting
      • Multiple Myeloma
      • +4 more
      • Total Body Irradiation
      • +5 more
      • Los Angeles, California
        Cedars Sinai Medical Center
      Dec 21, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022